Pemphigus vulgaris exhibiting Koebner phenomenon.
Ginarte
M
M
Sánchez-Aguilar
D
D
Pereiro-Ferreirós
M M
MM
Toribio
J
J
D000477:Alkylating Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications*; D003520:Cyclophosphamide / Q000627:therapeutic use; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000188:drug therapy / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use
D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D003520:Cyclophosphamide; D011241:Prednisone